Work

A new concept for bisphosphonate therapy: a rationale for the development of monthly oral dosing of ibandronate

Year: 2005

Type: review

Source: Osteoporosis International

DOI: 10.1007/s00198-005-1957-6

Authors: Jean-Yves Reginster, Dieter Felsenberg, Cyrus Cooper, Jacob A. Stakkestad, Paul D Miller, David L. Kendler, Silvano Adami, Michael R. McClung, Michael A. Bolognese, Roberto Civitelli, Etienne Dumont, Bernard Bonvoisin, Robert R Recker, Pierre D. Delmas

Institutions: University of Liège, Centre Hospitalier Universitaire de Liège, Southampton General Hospital, Colorado Center for Bone Research, University of British Columbia, University of Verona, Barnes-Jewish Hospital, Washington University in St. Louis, GlaxoSmithKline (United Kingdom), GlaxoSmithKline (United States), F. Hoffmann-La Roche AG, Creighton University, Lyon 1 Université, Inserm

Language: English

Topic: Bone health and osteoporosis research

Subfield: Orthopedics and Sports Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2007180210

FWCI: 1.47

Cites: 59

Cited by: 40

Related to: 10